Clinical Trial Update: Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating weekly carboplatin and docetaxel in platinum-sensitive relapsed ovarian, fallopian tube, or primary peritoneal cancers has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Saskatchewan | Conditions: Platinum Sensitive Relapsed Ovarian Cancer | Phase 2 | Status: TERMINATED